252 related articles for article (PubMed ID: 18003990)
1. Feasibility and efficacy of percutaneous transcatheter intraarterial chemotherapy with paclitaxel in albumin nanoparticles for advanced squamous-cell carcinoma of the oral cavity, oropharynx, and hypopharynx.
Damascelli B; Patelli G; Tichá V; Di Tolla G; Frigerio LF; Garbagnati F; Lanocita R; Marchianò A; Spreafico C; Mattavelli F; Bruno A; Zunino F
J Vasc Interv Radiol; 2007 Nov; 18(11):1395-403. PubMed ID: 18003990
[TBL] [Abstract][Full Text] [Related]
2. A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findings.
Damascelli B; Patelli GL; Lanocita R; Di Tolla G; Frigerio LF; Marchianò A; Garbagnati F; Spreafico C; Tichà V; Gladin CR; Palazzi M; Crippa F; Oldini C; Calò S; Bonaccorsi A; Mattavelli F; Costa L; Mariani L; Cantù G
AJR Am J Roentgenol; 2003 Jul; 181(1):253-60. PubMed ID: 12818869
[TBL] [Abstract][Full Text] [Related]
3. Response to intraarterial induction chemotherapy: a prognostic parameter in oral and oropharyngeal cancer.
Kovács AF
Head Neck; 2006 Aug; 28(8):678-88. PubMed ID: 16721739
[TBL] [Abstract][Full Text] [Related]
4. [Clinical trial of chemotherapy by superselective intra-arterial infusion of nedaplatin combined with radiotherapy for advanced oral cancer].
Yamshita Y; Shikimori M; Goto M
Gan To Kagaku Ryoho; 2005 Sep; 32(9):1267-71. PubMed ID: 16184922
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy protocol for stage III or IV carcinoma of the oral cavity, oropharynx and hypopharynx.
Schuller DE; King GW; Smith RE; Wilson HE; James AD; Batley F
Laryngoscope; 1980 Aug; 90(8 Pt 1):1263-72. PubMed ID: 7401827
[TBL] [Abstract][Full Text] [Related]
6. Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience.
Schuller DE; Ozer E; Agrawal A; Grecula JC; Rhoades CA; Young DC
Arch Otolaryngol Head Neck Surg; 2007 Apr; 133(4):320-6. PubMed ID: 17438244
[TBL] [Abstract][Full Text] [Related]
7. Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer.
Ibrahim NK; Samuels B; Page R; Doval D; Patel KM; Rao SC; Nair MK; Bhar P; Desai N; Hortobagyi GN
J Clin Oncol; 2005 Sep; 23(25):6019-26. PubMed ID: 16135470
[TBL] [Abstract][Full Text] [Related]
8. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
[TBL] [Abstract][Full Text] [Related]
9. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of paclitaxel and nedaplatin as first-line chemotherapy in patients with advanced esophageal cancer.
Cao W; Xu C; Lou G; Jiang J; Zhao S; Geng M; Xi W; Li H; Jin Y
Jpn J Clin Oncol; 2009 Sep; 39(9):582-7. PubMed ID: 19509000
[TBL] [Abstract][Full Text] [Related]
11. Treatment of base of tongue cancer with paclitaxel, ifosfamide, and cisplatinum induction chemotherapy followed by chemoradiotherapy.
Hancock SB; Krempl GA; Canfield V; Bogardus C; Kojouri K; Kaneaster SK; Medina JE
Laryngoscope; 2008 Aug; 118(8):1357-61. PubMed ID: 18528311
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
13. Phase II clinical trial of parenteral hydroxyurea and hyper-fractionated, accelerated external beam radiation therapy in patients with advanced squamous cell carcinoma of the head and neck: toxicity and efficacy with continuous ribonucleoside reductase inhibition.
Beitler JJ; Smith RV; Owen RP; Silver CE; Mazumdar M; Wadler S
Head Neck; 2007 Jan; 29(1):18-25. PubMed ID: 16983691
[TBL] [Abstract][Full Text] [Related]
14. Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.
Rossi D; Dennetta D; Ugolini M; Alessandroni P; Catalano V; Fedeli SL; Giordani P; Casadei V; Baldelli AM; Graziano F; Catalano G
Clin Lung Cancer; 2008 Sep; 9(5):280-4. PubMed ID: 18824450
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of intra-arterial infusion chemotherapy for head and neck cancers using coaxial catheter technique: initial experience.
Tsurumaru D; Kuroiwa T; Yabuuchi H; Hirata H; Higaki Y; Tomita K
Cardiovasc Intervent Radiol; 2007; 30(2):207-11. PubMed ID: 17216381
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of weekly paclitaxel and epirubicin in recurrent or refractory squamous cell carcinoma of the head and neck.
Wang TF; Chu SC; Kao RH; Yao CY; Li CC
Jpn J Clin Oncol; 2008 Jul; 38(7):459-63. PubMed ID: 18586668
[TBL] [Abstract][Full Text] [Related]
17. [The remission of extensive cancers of the mouth and oropharynx with intra-arterial polychemotherapy with vincristine, methotrexate, bleomycin, cisplatin (VMBP)].
Mika H
Laryngol Rhinol Otol (Stuttg); 1982 Sep; 61(9):520-3. PubMed ID: 6183545
[TBL] [Abstract][Full Text] [Related]
18. Superselective intra-arterial infusion chemotherapy for stage III/IV squamous cell carcinomas of the oral cavity: midterm results.
Ikushima I; Korogi Y; Ishii A; Hirai T; Yamura M; Nishimura R; Baba Y; Yamashita Y; Shinohara M
Eur J Radiol; 2008 Apr; 66(1):7-12. PubMed ID: 17604932
[TBL] [Abstract][Full Text] [Related]
19. Intra-arterial chemoradiation for T3-4 oral cavity cancer: treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma.
Doweck I; Robbins KT; Samant S; Vieira F
World J Surg Oncol; 2008 Jan; 6():2. PubMed ID: 18194553
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of a multimodal intensification regimen for previously untreated advanced resectable squamous cell cancer of the oral cavity, oropharynx, or hypopharynx.
Ozer E; Grecula JC; Agrawal A; Rhoades CA; Young DC; Schuller DE
Laryngoscope; 2006 Apr; 116(4):607-12. PubMed ID: 16585867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
